TEM
Tempus AI, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Sep 3 Trial readout: T-90d Trial Readout: A2B530 (Phase 2)
- Sep 8 2 analysts initiate
- Sep 9 UBS initiates
- Sep 17 to Sep 25 ▼ 3 days of insider sells: $35.6M by 4 insiders, avg $78.82
- Sep 21 Goldman Sachs initiates
- Sep 30 ▲ 9 funds open new positions (13F)
- Oct 23 ▲ Tempus AI announced a series of agreements with Bristol-Myers Squibb…
- Oct 27 to Nov 2 ▼ 2 days of insider sells: $17.6M by 3 insiders, avg $70.37
- Nov 2 ▲ The company raised full-year 2026 revenue guidance to $1.60-$1.605B…
- Nov 2 ▲ Earnings: TEM Q3 2026 Earnings: EPS $0.07 (+188.1% vs est)
- Nov 3 ▲ Jefferies upgrades
- Nov 9 Contract: SOTERIA Collaborates with Tempus to Advance Precision Onco…
Signal stack
Where each data set points today.
- InsidersBEARISH
6 insiders sold $53.2M.
- InstitutionsBULLISH
Q3 2026: 48 added (9 new), 20 trimmed or exited. Largest new: 1832 Asset Management $25.6M, Nomura Asset Management $16.7M.
- AnalystsBULLISH
14 of 27 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −3.3% to 24.54M shares. 4.5 days to cover, ≈13.4% of shares.
- TrendRANGE
11% below its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 5 mentions: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| MORGAN STANLEY | TRIM | $170.1M |
| BNP PARIBAS FINANCIAL MARKETS | DOUBLED | $103.6M |
| Invesco Ltd. | DOUBLED | $83.6M |
| Nuveen, LLC | ADD | $43.3M |
| Pictet Asset Management Holding SA | DOUBLED | $41.2M |
| BARCLAYS PLC | ADD | $38.2M |
| FIRST TRUST ADVISORS LP | ADD | $37.4M |
| Jump Financial, LLC | ADD | $32.9M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
27 analystsPrice is below the lowest target. Median implies +38%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 3, 2026 | Freedom Capital Markets MAINTAIN | Hold |
| Nov 3, 2026 | HC Wainwright & Co. MAINTAIN | Buy |
| Nov 3, 2026 | Baird MAINTAIN | Outperform |
| Nov 3, 2026 | Cantor Fitzgerald MAINTAIN | Overweight |
| Nov 3, 2026 | Jefferies UPGRADE | Hold |
| Nov 3, 2026 | BTIG MAINTAIN | Buy |
Washington
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Fukushima Ryan CEO, Data Nov 2, 2026 | AWARD | 100,000 sh |
Epstein David R Director Nov 2, 2026 | SELL | $27.5K |
Fukushima Ryan CEO, Data Nov 2, 2026 | SELL | $5.9K |
LEFKOFSKY ERIC P CEO and Chairman Oct 27, 2026 | SELL | $1.1M |
LEFKOFSKY ERIC P CEO and Chairman Oct 27, 2026 | SELL | $445.5K |
LEFKOFSKY ERIC P CEO and Chairman Oct 27, 2026 | SELL | $702.4K |
LEFKOFSKY ERIC P CEO and Chairman Oct 27, 2026 | SELL | $1.7M |
LEFKOFSKY ERIC P CEO and Chairman Oct 27, 2026 | SELL | $155.1K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | -$0.10 | -$0.58–$0.01 | +60.5% | $1.6B |
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
44 filings · 1 press release · 9 bullish · 9 bearish · 1 mixed · 25 neutral- NEUTRAL PRESS RELEASENov 9, 2026
SOTERIA Precision Medicine Foundation announced a collaboration with Tempus to provide genomic…
The collaboration is a non-financial partnership with a non-profit; no revenue or volume commitments are stated. Monitor future Tempus filings for any revenue recognition or expanded government…
- NEUTRAL SC 13G/ANov 6, 2026
ARK Investment Management LLC and Catherine D. Wood filed an amended Schedule 13G disclosing…
ARK's reduction below 5% removes the requirement for future 13G amendments, reducing transparency into their position changes. Monitor ARK's next 13F filing for the full extent of the reduction and…
- NEUTRAL CLUSTERNov 4, 2026
CEO Eric Lefkofsky sold $1.1M of TEM stock under a 10b5-1 plan two days after the company raised…
The CEO's sale is small relative to market cap and executed under a 10b5-1 plan, making it routine. Monitor for any acceleration of insider selling or changes to 10b5-1 plans in future filings.
- NEUTRAL 144Nov 2, 2026
Ryan Fukushima, an officer of Tempus AI, filed a Form 144 notice of intent to sell 80 shares of…
The filing is a routine, de minimis insider sale under a 10b5-1 plan. No material signal for the stock. Monitor for any larger insider sales or changes in officer holdings in future filings.
All TEM filing & press-release reports (45)
- PRESS-RELEASE reportNov 9, 2026
- SC 13G/A reportNov 6, 2026
- CLUSTER reportNov 4, 2026
- 144 reportNov 2, 2026
- 8-K reportNov 2, 2026
- SC 13G/A reportOct 28, 2026
- INST-CLUSTER reportOct 28, 2026
- 144 reportOct 27, 2026
- 8-K reportOct 23, 2026
- EFFECT reportOct 22, 2026
- S-4/A reportOct 20, 2026
- CLUSTER reportSep 29, 2026
- CLUSTER reportSep 24, 2026
- CLUSTER reportSep 18, 2026
- 144 reportSep 17, 2026
- CLUSTER reportSep 3, 2026
- CLUSTER reportSep 3, 2026
- CLUSTER reportSep 1, 2026
- CLUSTER reportAug 27, 2026
- CLUSTER reportAug 25, 2026
- 144 reportAug 25, 2026
- CLUSTER reportAug 20, 2026
- 144 reportAug 19, 2026
- CLUSTER reportAug 18, 2026
- CLUSTER reportAug 11, 2026
- CLUSTER reportAug 5, 2026
- 8-K reportJul 30, 2026
- 425 reportJul 20, 2026
- 425 reportJul 20, 2026
- 425 reportJul 20, 2026
- 425 reportJul 20, 2026
- 8-K reportJul 20, 2026
- 425 reportJul 20, 2026
- 8-K reportJul 20, 2026
- CLUSTER reportJul 8, 2026
- CLUSTER reportJul 1, 2026
- CLUSTER reportJun 29, 2026
- 144 reportJun 29, 2026
- INST-CLUSTER reportJun 12, 2026
- CLUSTER reportJun 3, 2026
- 144 reportMay 27, 2026
- CLUSTER reportMay 21, 2026
- DEFA14A reportApr 7, 2026
- CLUSTER reportMar 2, 2026
- 8-K, 8-K reportFeb 24, 2026